Stock XTNT XTANT MEDICAL HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Xtant Medical Holdings, Inc.

Equities

XTNT

US98420P3082

Market Closed - Nyse
Other stock markets
 04:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
0.7676 USD -1.59% Intraday chart for Xtant Medical Holdings, Inc. +10.86% -32.07%
May. 15 Earnings Flash (XTNT) XTANT MEDICAL HOLDINGS Reports Q1 Revenue $27.9M, vs. Street Est of $25.8M MT
May. 15 Transcript : Xtant Medical Holdings, Inc., Q1 2024 Earnings Call, May 15, 2024

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Sales forecast by analysts have been recently revised upwards.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • For the past year, analysts have significantly revised downwards their profit estimates.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
XTANT MEDICAL HOLDINGS, INC. Stock Xtant Medical Holdings, Inc.
-32.07% 99.95M -
STRYKER CORPORATION Stock Stryker Corporation
+10.24% 126B
A-
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-10.25% 10.89B
A-
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+3.31% 9.02B
C
GLAUKOS CORPORATION Stock Glaukos Corporation
+35.16% 5.41B
B+
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-23.90% 4.6B
C
AXONICS, INC. Stock Axonics, Inc.
+8.20% 3.44B
C-
ENOVIS CORPORATION Stock Enovis Corporation
-10.69% 2.74B
B-
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-12.15% 2.06B - -
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-11.96% 1.96B -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. XTNT Stock
  4. Ratings Xtant Medical Holdings, Inc.